{
  "url": "https://www.law.cornell.edu/regulations/new-york/9-NYCRR-4120.3",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 9 ยง 4120.3 - Equine drug thresholds; per se",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 9 ยง 4120.3 - Equine drug thresholds; per se\n\nState Regulations\n(a) A horse\nshall have raced in violation of this section if any of the following\nsubstances is found, by the laboratory conducting tests for the commission, to\nbe present in a race-day urine or blood sample taken from such horse at a\nconcentration in excess of a threshold listed below. The test result of such\nlaboratory shall include an assessment of the measurement uncertainty and\nimprecision of the quantitative threshold for the substance. (1)\n\nAcepromazine: 10 ng/ml HEPS in\nurine; (2)\n\nAlbuterol: 1 ng/ml in\nurine; (3)\n\nButorphanol: (i) 300 ng/ml of total butorphanol in urine; or\n(ii)\n2 ng/ml of free butorphanol\nin plasma; (4)\n\nCetirizine: 6 ng/ml in plasma; (5)\n\nCimetidine: 400 ng/ml in plasma; (6)\n\nCobalt: 50 ng/ml in plasma; (7)\n\nDantrolene: 100 pg/ml of\n5-hydroxydantrolene in plasma; (8)\n\nDetomidine: (i) 2 ng/ml of any metabolite of\ndetomidine in urine; or\n(ii)\n1\nng/ml of detomidine in plasma; (9)\n\nDiclofenac: 5 ng/ml in plasma; (10)\nDMSO: 10 mcg/ml in plasma; (11)\n\nFirocoxib: 20 ng/ml in plasma; (12)\n\nFlunixin: 20 ng/ml in plasma; (13)\n\nFurosemide: 100 ng/ml in plasma and a\nspecific gravity of urine less than 1.010; (14)\n\nGlycopyrrolate: 3 pg/ml in\nplasma; (15)\n\nGuaifenesin: 12 ng/ml\nin plasma; (16)\n\nKetoprofen: 2 ng/ml\nin plasma; (17)\n\nLidocaine: 20 pg/ml\nof total 3-hydroxylidocaine in plasma; (18)\n\nMepivacaine: (i) 10 ng/ml of total hydroxymepivacaine in\nurine; or\n(ii)\nany\nhydroxymepivacaine in plasma; (19)\n\nMethocarbamol: 1 ng/ml in plasma; (20)\n\nMethylprednisolone: 100 pg/ml in\nplasma; (21)\n\nOmeprazole: 10 ng/ml\nof omeprazole sulfide in plasma; (22)\n\nPhenylbutazone: 2 mcg/ml in\nplasma; (23)\n\nProcaine penicillin: 25 ng/ml of procaine in plasma; (24)\n\nRanitdine: 40 ng/ml in plasma; and\n(25)\n\nXylazine: 200 pg/ml in\nplasma. (b) A laboratory\nfinding that a horse has not exceeded a threshold set forth in this section\nshall not constitute a defense to a violation of any other section of this\n\nSubchapter. (c) A person who is\nfound responsible for a violation of this section for the substance cobalt, when the detected concentration of cobalt exceeds 300 ng/ml in plasma, shall\nincur the same penalty described in paragraph (2) of subdivision (d) of section\n4120.17\nof this Part. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 9\nยง\n4120.3\n\nAdopted, New\n\nYork State Register January 21, 2015/Volume XXXVII, Issue 03, eff. 4/1/2015\n\nAmended\n\nNew\n\nYork State Register February 10, 2016/Volume XXXVIII, Issue 06, eff. 2/10/2016\n\nAmended\n\nNew\n\nYork State Register June 2, 2021/Volume XLIII, Issue 22, eff. 6/2/2021\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 43473
}